PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Securities Trading Plans of Directors and Executive Officers
During our last fiscal quarter ended June 30, 2026, Jim R. Gibson, our Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement on May 22, 2026. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended, has a planned duration from August 21, 2026 through March 15, 2027, and provides for the potential sale of up to 661,685 shares of the Company's common stock.
Other than as disclosed above, none of our directors or officers, as defined in Rule 16a-1(f), adopted and/orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408.
| Q2 Fiscal 2026 Form 10-Q | 88 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.